These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26905417)

  • 21. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
    Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
    PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction.
    Zeller M; Masson D; Farnier M; Lorgis L; Deckert V; Pais de Barros JP; Desrumaux C; Sicard P; Grober J; Blache D; Gambert P; Rochette L; Cottin Y; Lagrost L
    J Am Coll Cardiol; 2007 Nov; 50(20):1948-55. PubMed ID: 17996559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moderate hyperalphalipoproteinaemia in a Brazilian population is related to lipoprotein lipase activity, apolipoprotein A-I concentration, age and body mass index.
    Alarcon SB; Oliveira HC; Harada LM; Nunes VS; Kaplan D; Quintão EC; de Faria EC
    Clin Sci (Lond); 2004 Jan; 106(1):11-7. PubMed ID: 12889988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.
    Borggreve SE; Hillege HL; Dallinga-Thie GM; de Jong PE; Wolffenbuttel BH; Grobbee DE; van Tol A; Dullaart RP;
    Eur Heart J; 2007 Apr; 28(8):1012-8. PubMed ID: 17409111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
    Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
    Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined use of short-term and long-term cardiovascular risk scores in primary prevention: an assessment of clinical utility.
    Veronesi G; Giampaoli S; Vanuzzo D; Gianfagna F; Palmieri L; Grassi G; Cesana G; Ferrario MM
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):318-324. PubMed ID: 28151772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.
    Asztalos BF; Collins D; Cupples LA; Demissie S; Horvath KV; Bloomfield HE; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2185-91. PubMed ID: 16123324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults.
    Takeuchi T; Nemoto K; Takahashi O; Urayama KY; Deshpande GA; Izumo H
    J Clin Lipidol; 2014; 8(5):501-9. PubMed ID: 25234563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study.
    Kappelle PJ; Perton F; Hillege HL; Dallinga-Thie GM; Dullaart RP
    Atherosclerosis; 2011 Jul; 217(1):249-52. PubMed ID: 21524747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A potential screening factor for accumulation of cholesteyl ester transfer protein deficiency in East Asia: Schistosoma japonicum.
    Yokoyama S
    Biochim Biophys Acta; 2014 Apr; 1841(4):495-504. PubMed ID: 24388961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-density lipoprotein particles, coronary heart disease, and niacin.
    Asztalos BF
    J Clin Lipidol; 2010; 4(5):405-10. PubMed ID: 21122684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events.
    Laitinen DL; Manthena S
    Adv Ther; 2010 Apr; 27(4):233-44. PubMed ID: 20437214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation).
    Nicholls SJ; Tuzcu EM; Brennan DM; Tardif JC; Nissen SE
    Circulation; 2008 Dec; 118(24):2506-14. PubMed ID: 19029466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease.
    Bu XM; Niu DM; Wu J; Yuan YL; Song JX; Wang JJ
    Lipids Health Dis; 2017 Jan; 16(1):4. PubMed ID: 28073362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.
    Hero C; Svensson AM; Gidlund P; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K
    Diabet Med; 2016 Mar; 33(3):316-23. PubMed ID: 26498834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment.
    Whitehead SJ; Ford C; Gama R
    J Clin Pathol; 2014 Jun; 67(6):535-9. PubMed ID: 24711512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.